Dylan Coronado
Pharmacogenomic testing for SSRIs analyzes CYP2C19 and CYP2D6 genes to predict how your body metabolizes antidepressants. This can prevent severe side effects by matching drug choice and dose to your genetics.
Aug 8 2026
Apr 4 2026
Dec 30 2025
Aug 12 2026
Dec 8 2025